Sevelamer Carbonate Tablet, Film Coated
Product Images NDC 55154-3358

5 FDA label images from Cardinal Health 107, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 55154-3358). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
Chemical structure diagram of the active ingredient Sevelamer Carbonate, showing its polymeric amine groups and carbonate counter ions. The structure includes repeating units with amine (NH3+, NH2) and hydroxyl (OH) functionalities linked in a polymeric chain.*
FDA Label Image

Figure2 (Figure 2)

Figure2 (Figure 2)
A forest plot chart comparing Sevelamer Carbonate versus placebo across subgroups by screening BSA, baseline serum phosphorus, age, and dialysis status. The horizontal axis shows mean differences favoring Sevelamer Carbonate or placebo, with confidence intervals. Sample sizes and percentages are listed for each group on the right.*
FDA Label Image

Figure3 (Figure3)

Figure3 (Figure3)
A line chart depicting phosphorus change from baseline over a 52-week study period. The x-axis marks study weeks from 0 to 52; the y-axis shows phosphorus change ranging from -5 to 2. Two lines represent treatment groups: Sevelamer Hydrochloride and an active control, illustrating trends in phosphorus levels throughout the study.*
FDA Label Image

Figure4 (Figure4)

Figure4 (Figure4)
A line graph showing the phosphate change from baseline over a 52-week study period. The graph compares two treatments: Sevelamer Hydrochloride and an Active-Control, with phosphate change values plotted on the vertical axis and study weeks on the horizontal axis.*
FDA Label Image

800mg Bag Label (861910dd 653c 4652 B0e8 E78fa95ab8d9 00)

800mg Bag Label (861910dd 653c 4652 B0e8 E78fa95ab8d9 00)
Label for Sevelamer Carbonate Tablets 800 mg, film-coated oral tablets. The label indicates a package of 10 tablets and includes active ingredient information. It shows storage instructions to keep at 20°-25°C, a prescription-only drug warning, and manufacturer details including Dr. Reddy's Laboratories Limited, distributor Major Pharmaceuticals, and Cardinal Health in Dublin, OH. The label also contains a barcode and packaging warnings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.